SCOPESCREEN is dedicated to delivering medical products for the fertility, diagnostic and developmental biology marketplace. The business has been manufacturing products for evaluating male fertility since 1991.
Our products have been used for many years to establish a high standard of quality control monitoring and screening assays worldwide for all types of labs and clinics, including large reference and world-leading research labs.
SCOPESCREEN is focused on further developing its capabilities to advance healthcare testing, reduce screening costs and improve overall lab processes. SCOPESCREEN acquired Bioscreen in 2020.
SCOPESCREEN PRODUCT LINE